The PFOX trial: exertional hypoxaemia in fibrotic ILD

Kristopher P. Clark; Daniel J. Kass

doi:10.1016/S2213-2600(26)00041-X

The PFOX trial: exertional hypoxaemia in fibrotic ILD

Kristopher P. Clark
, Daniel J. Kass

Medicine

University of Pittsburgh

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	283-285
Number of pages	3
Journal	The Lancet Respiratory Medicine
Volume	14
Issue number	4
DOIs	https://doi.org/10.1016/S2213-2600(26)00041-X
State	Published - Apr 2026

Access to Document

10.1016/S2213-2600(26)00041-X

Cite this

@article{8106142ad59e4049be81dc6eb9ab7743,

title = "The PFOX trial: exertional hypoxaemia in fibrotic ILD",

author = "Clark, \{Kristopher P.\} and Kass, \{Daniel J.\}",

year = "2026",

month = apr,

doi = "10.1016/S2213-2600(26)00041-X",

language = "English",

volume = "14",

pages = "283--285",

journal = "The Lancet Respiratory Medicine",

issn = "2213-2600",

publisher = "Elsevier Ltd",

number = "4",

}

TY - JOUR

T1 - The PFOX trial

T2 - exertional hypoxaemia in fibrotic ILD

AU - Clark, Kristopher P.

AU - Kass, Daniel J.

PY - 2026/4

Y1 - 2026/4

UR - https://www.scopus.com/pages/publications/105031611113

U2 - 10.1016/S2213-2600(26)00041-X

DO - 10.1016/S2213-2600(26)00041-X

M3 - Comment/debate

C2 - 41765031

AN - SCOPUS:105031611113

SN - 2213-2600

VL - 14

SP - 283

EP - 285

JO - The Lancet Respiratory Medicine

JF - The Lancet Respiratory Medicine

IS - 4

ER -

The PFOX trial: exertional hypoxaemia in fibrotic ILD

Access to Document

Other files and links

Fingerprint

Cite this